Emerging Technologies

An Israeli AI startup has been cleared to market COVID-detecting voice analysis software in Europe, according to No Camels.

An AI startup’s virtual-patient technology is good enough at teaching empathy to clinicians that it’s already in use at Cedars-Sinai Medical Center in Los Angeles, the National Health Service in Britain and the University of Texas Medical Branch in Galveston.

Only two of 34 representative studies evaluating the use of AI for real-world shared clinical decisionmaking from 2014 to 2020 included external validation of the models up for consideration.

Healthcare AI is advancing too quickly for its users to fully comprehend the implications of its design, development and applications, according to bioethics specialists who scanned the literature. 

The government of Saudi Arabia is bringing in Royal Philips to help the country of 35 million become a global leader in healthcare AI.

The tool makes the call based on factors readily available to busy clinicians, respecting their workflows while helping patients and families decide whether moving to access a stepped-up care setting would fit well with their aims and values.

Two bioinformatics experts have used AI to accurately estimate regional COVID infection rates, aka seroprevalence, in all 50 states and 50 hard-hit countries.

The plan is to draw health data from every available source to continuously nudge individuals toward not only appropriate medical care but also healthier lifestyles.

Google Cloud has launched an AI-backed technology toolkit to help government health personnel direct COVID vaccine doses and other resources where they’re most needed.

Computer engineers have produced a deep learning framework for very quickly fine-tuning vaccines to fight emerging variant strains of COVID-19.

AI-based CDS tools that perform well in clinical trials will flounder on the way to clinical practice if they’re not evaluated early and thoroughly for their effects on real-world clinical decisionmaking.  

Hospital leaders discouraged by COVID-19’s devastating toll on human life and wellbeing must also mind the price the crisis is exacting on their organization’s financial health.  

Around the web

Two different companies announced that they are recalling all lots of the medication. 

CardioSmart, an online resource for both patients and clinicians, has a new editor. 

The funding includes $8.5 billion in American Rescue Plan resources for providers who treat Medicaid, Children's Health Insurance Program and Medicare patients.

   
   
   
   
   
Trimed Popup
Trimed Popup